DIA to host 8th annual conference on The New Clinical Research Environment in India: Implications and Opportunities

DIA will host the 8th annual conference on The New Clinical Research Environment in India: Implications and Opportunities from October 24 to 26 at the National Institute of Mental Health and Neuro Sciences’ convention centre in Bangalore. The three-day conference will provide a forum for academia, industry representatives, regulators and researchers to come together to discuss the new environment for healthcare product development in India. Express Pharma is a media partner to the event.

“New regulations have made the pursuit of clinical development in India extremely challenging, while the demand for services in the regulation-free domains of remote data processing and IT-enabled offerings is growing at an unprecedented scale,” said Kaushik Desai, Director for India, DIA. “Participants will hear about how their peers are coping with new regulations and how they are planning to realise the promise of emerging opportunities.”

Ranjit Roy Chaudhury, Chairman of the task force for research at the Apollo Hospitals Educational and Research Foundation, and Anu Acharya, Chief Executive Officer, Mapmygenome.com will serve as the keynote speakers. The first session, ‘Vaccine Development – A Challenge Like No Other,” will address the imperatives for India in vaccine development and identify the risks and benefits to patients participating in vaccine trials.

Workshop sessions will have Session 1B: Global Development of Biosimilars, Session 2C: IT in Clinical Records and Collaboration; Session 5AB: Compensation for Injuries to Participants in Research: A Trans-National Perspective; Session 7C: SMAC (Social Media, Mobility, Analytics and Cloud) or New Technologies.

EP News Bureau – Mumbai